BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22387297)

  • 1. Detection of circulating tumor-associated antigen depends on the domains recognized by the monoclonal antibodies used: N-terminal trimmed EpCAM-levels are much higher than untrimmed forms.
    Schmetzer O; Moldenhauer G; Nicolaou A; Schlag P; Riesenberg R; Pezzutto A
    Immunol Lett; 2012 Apr; 143(2):184-92. PubMed ID: 22387297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteine-poor region-specific EpCAM monoclonal antibody recognizing native tumor cells with high sensitivity.
    Takao M; Nagai Y; Torii T
    Monoclon Antib Immunodiagn Immunother; 2013 Apr; 32(2):73-80. PubMed ID: 23607341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide arrays for the determination of humoral responses induced by active immunization with a monoclonal antibody against EpCAM.
    Dürauer A; Berger E; Schuster M; Wasserbauer E; Himmler G; Loibner H; Mudde GC; Jungbauer A
    J Immunol Methods; 2006 Dec; 317(1-2):114-25. PubMed ID: 17069841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of EpCAM ectodomain as found in sera of cancer patients do not significantly impact redirected lysis and T-cell activation by EpCAM/CD3-bispecific BiTE antibody MT110.
    Petsch S; Gires O; Rüttinger D; Denzel S; Lippold S; Baeuerle PA; Wolf A
    MAbs; 2011; 3(1):31-7. PubMed ID: 21107020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of recombinant protein determines the amount of autoreactivity detected against the tumor-associated epithelial cell adhesion molecule antigen: low frequency of antibodies against the natural protein.
    Schmetzer O; Moldenhauer G; Riesenberg R; Pires JR; Schlag P; Pezzutto A
    J Immunol; 2005 Jan; 174(2):942-52. PubMed ID: 15634917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma.
    Moldenhauer G; Salnikov AV; Lüttgau S; Herr I; Anderl J; Faulstich H
    J Natl Cancer Inst; 2012 Apr; 104(8):622-34. PubMed ID: 22457476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yeast cell surface display system for determination of humoral response to active immunization with a monoclonal antibody against EpCAM.
    Dürauer A; Berger E; Zandian M; Mersich C; Schuster M; Loibner H; Jungbauer A
    J Biochem Biophys Methods; 2008 Apr; 70(6):1109-15. PubMed ID: 18321588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of an anti-EpCAM antibody and epigenetic regulation of EpCAM in colorectal cancer.
    Liao MY; Kuo MY; Lu TY; Wang YP; Wu HC
    Int J Oncol; 2015 Apr; 46(4):1788-800. PubMed ID: 25652097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution studies of epithelial cell adhesion molecule (EpCAM)-directed monoclonal antibodies in the EpCAM-transgenic mouse tumor model.
    Kosterink JG; McLaughlin PM; Lub-de Hooge MN; Hendrikse HH; van Zanten J; van Garderen E; Harmsen MC; de Leij LF
    J Immunol; 2007 Jul; 179(2):1362-8. PubMed ID: 17617629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of carcinoembryonic antigen (CEA), epidermal growth factor receptor (EGFR), epithelial cell adhesion molecule EpCAM (GA733-2), and carbohydrate antigen 19-9 (CA 19-9) levels in colorectal cancer patients and correlation with clinicopathological characteristics.
    Mourtzikou A; Stamouli M; Kroupis C; Christodoulou S; Skondra M; Kastania A; Pectasides D; Athanasas G; Dimas C
    Clin Lab; 2012; 58(5-6):441-8. PubMed ID: 22783573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EpCAM-autoantibody levels in the course of disease of ovarian cancer patients.
    Heubner M; Errico D; Kasimir-Bauer S; Herlyn D; Kimmig R; Wimberger P
    Med Oncol; 2011 Jun; 28(2):626-30. PubMed ID: 20383668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EpCAM- and EGFR-targeted selective gene therapy for biliary cancers using Z33-fiber-modified adenovirus.
    Kawashima R; Abei M; Fukuda K; Nakamura K; Murata T; Wakayama M; Seo E; Hasegawa N; Mizuguchi H; Obata Y; Hyodo I; Hamada H; Yokoyama KK
    Int J Cancer; 2011 Sep; 129(5):1244-53. PubMed ID: 21710497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the specificity and selectivity of anti-EpCAM antibodies in breast cancer cell lines.
    Sterzynska K; Kempisty B; Zawierucha P; Zabel M
    Folia Histochem Cytobiol; 2012; 50(4):534-41. PubMed ID: 23264216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naturally occurring antibodies to epithelial cell adhesion molecule (EpCAM).
    Kirman I; Jenkins D; Fowler R; Whelan RL
    Dig Dis Sci; 2003 Dec; 48(12):2306-9. PubMed ID: 14714617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of mAbs targeting epithelial cell adhesion molecule for the detection of prostate cancer lymph node metastases with multimodal contrast agents: quantitative small-animal PET/CT and NIRF.
    Hall MA; Pinkston KL; Wilganowski N; Robinson H; Ghosh P; Azhdarinia A; Vazquez-Arreguin K; Kolonin AM; Harvey BR; Sevick-Muraca EM
    J Nucl Med; 2012 Sep; 53(9):1427-37. PubMed ID: 22872743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenic regions of the GA733-2 tumour-associated antigen recognised by autoantibodies of patients with colorectal carcinoma.
    Mosolits S; Steinitz M; Harmenberg U; Ruden U; Eriksson E; Mellstedt H; Fagerberg J
    Cancer Immunol Immunother; 2002 Jun; 51(4):209-18. PubMed ID: 12012108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of recombinant MK-1/Ep-CAM and establishment of an ELISA system for determining soluble MK-1/Ep-CAM levels in sera of cancer patients.
    Abe H; Kuroki M; Imakiire T; Yamauchi Y; Yamada H; Arakawa F; Kuroki M
    J Immunol Methods; 2002 Dec; 270(2):227-33. PubMed ID: 12379327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An anti-EpCAM antibody EpAb2-6 for the treatment of colon cancer.
    Liao MY; Lai JK; Kuo MY; Lu RM; Lin CW; Cheng PC; Liang KH; Wu HC
    Oncotarget; 2015 Sep; 6(28):24947-68. PubMed ID: 26317650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum antibodies to EpCAM in healthy donors but not ulcerative colitis patients.
    Furth EE; Li J; Purev E; Solomon AC; Rogler G; Mick R; Putt M; Zhang T; Somasundaram R; Swoboda R; Herlyn D
    Cancer Immunol Immunother; 2006 May; 55(5):528-37. PubMed ID: 16034560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-EpCAM modified LC-SPDP monolayer on gold microelectrode based electrochemical biosensor for MCF-7 cells detection.
    Arya SK; Wang KY; Wong CC; Rahman AR
    Biosens Bioelectron; 2013 Mar; 41():446-51. PubMed ID: 23021854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.